PubMed HealthSearch

Biomedical subjects

D W Ruck

Publications and source records attributed to D W Ruck.

3 recordsLinked to original sources

Selecting optimal experiments for multiple output multilayer perceptrons.

Where should a researcher conduct experiments to provide training data for a multilayer perceptron? This question is investigated, and a statistical method for selecting optimal experimental design points for multiple output multilayer perceptrons is introduced. Multiple class discrimination problems are examined using a framework in which the multilayer perceptron is viewed as a multivariate nonlinear regression model. Following a Bayesian formulation for the case where the variance-covariance matrix of the responses is unknown, a selection criterion is developed. This criterion is based on the volume of the joint confidence ellipsoid for the weights in a multilayer perceptron. An example is used to demonstrate the superiority of optimally selected design points over randomly chosen points, as well as points chosen in a grid pattern. Simplification of the basic criterion is offered through the use of Hadamard matrices to produce uncorrelated outputs.

Algorithms

Computer-aided breast cancer detection and diagnosis of masses using difference of Gaussians and derivative-based feature saliency.

A new model-based vision (MBV) algorithm is developed to find regions of interest (ROI's) corresponding to masses in digitized mammograms and to classify the masses as malignant/benign. The MBV algorithm is comprised of five modules to structurally identify suspicious ROI's, eliminate false positives, and classify the remaining as malignant or benign. The focus of attention module uses a difference of Gaussians (DoG) filter to highlight suspicious regions in the mammogram. The index module uses tests to reduce the number of nonmalignant regions from 8.39 to 2.36 per full breast image. Size, shape, contrast, and Laws texture features are used to develop the prediction module's mass models. Derivative-based feature saliency techniques are used to determine the best features for classification. Nine features are chosen to define the malignant/benign models. The feature extraction module obtains these features from all suspicious ROI's. The matching module classifies the regions using a multilayer perceptron neural network architecture to obtain an overall classification accuracy of 100% for the segmented malignant masses with a false-positive rate of 1.8 per full breast image. This system has a sensitivity of 92% for locating malignant ROI's. The database contains 272 images (12 b, 100 microm) with 36 malignant and 53 benign mass images. The results demonstrate that the MBV approach provides a structured order of integrating complex stages into a system for radiologists.

Algorithms

Artificial neural networks for early detection and diagnosis of cancer.

Why use neural networks? The reasons commonly cited in the literature for using artificial neural networks for any problem are many and varied. They learn from experience. They work where other algorithms fail. They generalize from the training examples to perform well on independent test data. They reduce the number of false alarms without increasing significantly the number of false negatives. They are fast and are easier to use than conventional statistical techniques, especially when multiple prognostic factors are needed for a given problem. These factors have been overly promoted for the neural techniques. The common theme of this paper is that artificial neural networks have proven to be an interesting and useful alternate processing strategy. Artificial neural techniques, however, are not magical solutions with mystical abilities that work without good engineering. With good understanding of their capabilities and limitations they can be applied productively to problems in early detection and diagnosis of cancer. The specific cancer applications which will be used to demonstrate current work in artificial neural networks for cancer detection and diagnosis are breast cancer, liver cancer and lung cancer.

Diagnosis, Computer-Assisted